I believe that shareholders should vote for Gary Rabin as the CEO at this time. I have been amazed at the hypocrisy of posters who invested in a speculative penny stock, but who have cried over the CEO being a poker player. ACTC was on the verge of bankruptcy a few years ago, and there have been missteps, but we are still in the game. The Board and the CEO have made mistakes, and so have all of you. As the share price goes up, most investors won’t remember the problems. Keep in mind that there were times less than 20 years ago when you could not give Apple stock away. The Next and Lisa computers are not even good boat anchors. We can buy a CEO away from a small but successful pharmaceutical company, but why would we want to do that? The boat is running fine at this time given the cards dealt over the past. Further, many of the negative posts about our CEO fail to consider just what has been overcome in the past 5 years. After all that work with the prize being within reach you want a new commander? I have already voted for Gary Rabin, and you will to if you think about it.
Gary Rabin may not be a perfect match for a 3 piece suit pharmaceutical world, but we are on the verge of a new world. I don’t believe that we want or need a CEO who perfectly “fits” with the existing medical sales paradigm. The professionals who run the old world were not lining up to help out five years ago when the doors of the company were being held open by people like Gary Rabin making sacrifices to keep ACTC open. Everyone should agree that there are benefits to a joint-venture, but our CEO is correct in pointing out that you also have to weigh the costs of such a partnership. Mr. Rabin has made comments which have not made the shareholders happy, but I am happy with a leader who is not afraid to tell me the truth. We don’t get much of that anymore and I can appreciate the efforts made to get us this far.
I began investing in ACTC over five years ago because of Dr. Robert Lanza. Dr. Lanza’s work will likely be viewed as mythical for years to come. Comprehending the interaction of proteins with our cells, and figuring out how to make the human immune system functional once it gets off-track is beyond what most of us think of as “genius.” Especially when this is in addition to an amazing blood program and curing a large number of eye diseases. Each of these marvels by themselves would be a crowning achievement to any scientific career, but all this and more coming???? Dr. Lanza appears to be talking directly with the almighty, and this is the place to put your investment dollars.
This little company is about to transform into something wonderful. While we may need to make a change in the future, I do not believe that we should change the captain at this time. We do need additional funding, but now that more of ACTC’s future has been revealed, I will be investing more. I bought more shares this week, and I want the Board of Directors to keep ACTC out of the hands of larger pharmaceutical companies because I want ACTC to be “The Stem Cell Company.”
I want Gary Rabin as our CEO to double down, and show enough of his cards to keep ACTC in the game until a joint venture is truly beneficial. I am going all in on ACTC even if I take another short term loss before the real fireworks begin. I encourage other shareholders to do the same. Come on in the water’s fine.
AI
